Exercise and menopausal symptoms: a randomised controlled trial
ISRCTN | ISRCTN06495625 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN06495625 |
Secondary identifying numbers | 8367 |
- Submission date
- 10/11/2010
- Registration date
- 10/11/2010
- Last edited
- 16/09/2020
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Urological and Genital Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Amanda Daley
Scientific
Scientific
Department of Primary Care & General Practice
Primary Care Clinical Sciences Building
Edgbaston
Birmingham
B15 2TT
United Kingdom
a.daley@bham.ac.uk |
Study information
Study design | Single-centre randomised interventional treatment trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
Scientific title | The feasibility and acceptability of exercise as a treatment for vasomotor menopausal symptoms: a randomised controlled trial |
Study objectives | Many menopausal women are keen to find alternatives to hormone replacement therapy (HRT); exercise might be a useful intervention in this regard. There has been a lack of robust research on the effects of exercise upon vasomotor symptoms as evidenced by our recent Cochrane review, which concluded that research in this field is very limited and of low quality. Our previous pilot work has already established that exercise is likely to be acceptable to menopausal aged women. In addition, we have now established women's preferences for different types of exercise and modes of delivery. We now need to determine the feasibility and acceptability of the preferred exercise interventions within the context of a randomised controlled trial (RCT). If exercise is shown to be feasible and subsequently effective in a phase III trial, then it would be possible for health professionals to discuss aerobic exercise as an evidence-based treatment option, specifically for the management of vasomotor symptoms. We will conduct a three-arm RCT with women randomised to one of two exercise interventions or control. The interventions will last 6 months. The primary outcome will be feasibility (adherence and recruitment). Secondary outcomes include quality of life, depression and self-efficacy for exercise. |
Ethics approval(s) | West Midlands Local Research Ethics Committee, 04/02/2010, ref: 10/H1208/3a |
Health condition(s) or problem(s) studied | Topic: Primary Care Research Network for England; Subtopic: Not Assigned; Disease: All Diseases |
Intervention | Physical activity 1: Exercise consultations plus DVD and booklet, plus leaflets Physical activity 2: Exercise consultations plus support/information groups Control: Treatment as usual Duration of treatment: 6 months Duration of follow-up: 6 months from baseline (i.e. end of treatment) Study entry: single randomisation only |
Intervention type | Other |
Primary outcome measure | Feasibility (recruitment and adherence), measured at baseline and 6-month follow-up |
Secondary outcome measures | 1. Depression, measured at baseline and 6-month follow-up 2. Menopause-specific quality of life, measured at baseline and 6-month follow-up 3. Physical activity (self report and objective), measured at baseline and 6-month follow-up 4. Self efficacy for exercise, measured at baseline and 6-month follow-up 5. Vasomotor symptoms, measured at baseline and 6-month follow-up |
Overall study start date | 01/01/2011 |
Completion date | 31/03/2012 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Sex | Female |
Target number of participants | Planned sample size: 165 |
Total final enrolment | 261 |
Key inclusion criteria | 1. Women aged 48 - 57 years who are experiencing vasomotor menopausal symptoms and have not used HRT in the previous 3 months 2. Spontaneously perimenopausal (irregular periods but at least one period in the previous 12 months) or menopausal women (no menstruation for greater than 12 months prior to study) 3. Inactive (not currently involved in a regular programme of exercise three or more times per week for at least 30 minutes per session during the previous 3 months) 4. Not dependent on illicit drugs or alcohol |
Key exclusion criteria | 1. Oral contraceptive, tamoxifen, tibolone and raloxifene usage in previous 3 months 2. Using HRT 3. Unable to provide informed consent 4. Not able to understand English sufficiently to complete the research questionnaires 5. GP considers patient unsuitable for the trial |
Date of first enrolment | 01/01/2011 |
Date of final enrolment | 31/03/2012 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
University of Birmingham
Birmingham
B15 2TT
United Kingdom
B15 2TT
United Kingdom
Sponsor information
University of Birmingham (UK)
University/education
University/education
Department of Primary Care & General Practice
Primary Care Clinical Sciences Building Edgbaston
Birmingham
B15 2TT
England
United Kingdom
Website | http://www.birmingham.ac.uk/index.aspx |
---|---|
https://ror.org/03angcq70 |
Funders
Funder type
Government
National Institute of Health Research (NIHR) (UK) - Research Capacity Development (ref: SRF/08/01/07)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Protocol article | protocol | 01/12/2013 | Yes | No | |
Results article | results | 01/03/2015 | Yes | No | |
Results article | qualitative results | 14/09/2020 | 16/09/2020 | Yes | No |
Editorial Notes
16/09/2020: The following changes have been made:
1. Publication reference added.
2. The total final enrolment number has been added from the 2015 reference. RP 30/04/2015: added pub.